SCHEMBL384952

SCHEMBL384952

c1ccc(-c2nnc(-c3ccccc3)[nH]2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.61
RAB9A P51151 3/20 0.61
POLB P06746 2/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
NPY5R Q15761 2/20 0.50
SCN2A Q99250 1/20 0.50
BTK Q06187 1/20 0.50
GAA P10253 3/20 0.48
MAPK1 P28482 2/20 0.48
MTOR P42345 1/20 0.46
ADK P55263 1/20 0.46
NISCH Q9Y2I1 1/20 0.46
ALDH1A1 P00352 4/20 0.44
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
DCUN1D1 Q96GG9 1/20 0.44
PIN1 Q13526 2/20 0.43
TNKS O95271 1/20 0.43
PARP1 P09874 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24317555 0.97 NPC1 (0.59) NPC1RAB9APOLBL3MBTL1NPY5R
SCHEMBL17948203 0.95 NPC1 (0.57) NPC1RAB9APOLBL3MBTL1NPY5R
Naphthalene SCHEMBL28228080 0.92 NPC1 (0.55) NPC1RAB9APOLBL3MBTL1NPY5R
SCHEMBL17574085 0.90 RAB9A (0.53) NPC1RAB9APOLBL3MBTL1NPY5R
SCHEMBL15058469 0.86 NPC1 (0.50) NPC1RAB9APOLBL3MBTL1NPY5R
SCHEMBL21067971 0.86 NPC1 (0.52) NPC1RAB9APOLBL3MBTL1NPY5R
SCHEMBL16661157 0.86 ALDH1A1 (0.58) NPC1RAB9APOLBL3MBTL1NPY5R
SCHEMBL8819870 0.84 NPC1 (0.48) NPC1RAB9APOLBL3MBTL1SCN2A
SCHEMBL143807 0.83 NPC1 (0.52) NPC1RAB9APOLBL3MBTL1NPY5R
SCHEMBL17731684 0.83 NPC1 (0.52) NPC1RAB9APOLBL3MBTL1NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1719200-B1 HIGH-PERFORMANCE MEMBRANE ELECTRODE UNIT AND THE USE THEREOF IN FUEL CELLS BASF FUEL CELL RES GMBH (DE) 2017-08-30 EP claimed
US-20260114156-A1 DISPLAY DEVICE, METHOD OF MANUFACTURING THE SAME AND ELECTRONIC DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2026-04-23 US disclosed
US-20260114163-A1 LENS ARRAY STRUCTURE, METHOD OF FABRICATING THE SAME, DISPLAY DEVICE INCLUDING THE SAME AND ELECTRONIC DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2026-04-23 US disclosed
US-12571105-B2 Metallic coated substrates ARMADILLO METAL COATINGS LTD (GB) 2026-03-10 US disclosed
US-20260068484-A1 DISPLAY DEVICE AND ELECTRONIC DEVICE SAMSUNG DISPLAY CO LTD (KR) 2026-03-05 US disclosed
US-12565613-B2 Quantum dots with donor-acceptor ligands SHOEI CHEMICAL INC. (JP) 2026-03-03 US disclosed
CN-117836293-A Tertiary amine derivative and organic electroluminescent device comprising same 株式会社乐普拓 2024-04-05 CN disclosed
CN-116724685-A Organic electroluminescent device and organic compound for organic electroluminescent device 株式会社乐普拓 2023-09-08 CN disclosed
CN-116710432-A Organic compound and organic electroluminescent device comprising the same 株式会社乐普拓 2023-09-05 CN disclosed
WO-2023073115-A1 PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2023-05-04 WO disclosed
WO-2003092090-A2 MULTILAYER ELECTROLYTE MEMBRANE PEMEAS GMBH (DE) 2003-11-06 WO disclosed
WO-2003075389-A1 MIXTURE COMPRISING PHOSPHONIC ACID CONTAINING VINYL, POLYMER ELECTROLYTE MEMBRANES COMPRISING POLYVINYLPHOSPHONIC ACID AND THE USE THEREOF IN FUEL CELLS PEMEAS GMBH (DE) 2003-09-12 WO disclosed
WO-2003074597-A1 PROTON CONDUCTING ELECTROLYTE MEMBRANE HAVING REDUCED METHANOL PERMEABILITY AND THE USE THEREOF IN FUEL CELLS PEMEAS GMBH (DE) 2003-09-12 WO disclosed
WO-2003074595-A1 MIXTURE COMPRISING SULPHONIC ACID CONTAINING VINYL, POLYMER ELECTROLYTE MEMBRANE COMPRISING POLYVINYLSULPHONIC ACID AND THE USE THEREOF IN FUEL CELLS PEMEAS GMBH (DE) 2003-09-12 WO disclosed
WO-2003074596-A1 PROTON CONDUCTING ELECTROLYTE MEMBRANE FOR USE IN HIGH TEMPERATURES AND THE USE THEREOF IN FUEL CELLS PEMEAS GMBH (DE) 2003-09-12 WO disclosed
US-4105631-A MULTICHROMOPHORIC ULTRAVIOLET STABILIZERS AND THEIR USE IN ORGANIC COMPOSITIONS EASTMAN KODAK COMPANY (US) 1978-08-08 US disclosed
US-4043973-A PIGMENTS, COLORANTS, FILLERS, REINFORCING AGENTS EASTMAN KODAK COMPANY (US) 1977-08-23 US disclosed
US-3963738-A Bis-oxadiazolyl phenyl aromatic diester compounds and their use as ultraviolet stabilizers in organic compositions EASTMAN KODAK COMPANY (US) 1976-06-15 US disclosed
US-3939115-A OXADIAZOLES EASTMAN KODAK COMPANY (US) 1976-02-17 US disclosed
US-3936419-A Multichromophoric ultraviolet stabilizers and their use in organic compositions EASTMAN KODAK COMPANY (US) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565613-B2 Quantum dots with donor-acceptor ligands HCCS, FDPS, FTH1 NPC1 169/4885RAB9A 1423/4885POLB 2674/4885
US-20260114163-A1 LENS ARRAY STRUCTURE, METHOD OF FABRICATING THE SAME, DISPLAY DEVICE INCLUDING THE SAME AND ELECTRONIC DEVICE INCLUDING THE SAME JUND, AXL, ZKSCAN2 NPC1 2689/4885RAB9A 767/4885POLB 4407/4885
US-12571105-B2 Metallic coated substrates SOD1, TET1, TST NPC1 4388/4885RAB9A 4152/4885POLB 503/4885
US-20260114156-A1 DISPLAY DEVICE, METHOD OF MANUFACTURING THE SAME AND ELECTRONIC DEVICE INCLUDING THE SAME VCL, VSIG8, ICOSLG NPC1 4701/4885RAB9A 3465/4885POLB 3946/4885
US-20260068484-A1 DISPLAY DEVICE AND ELECTRONIC DEVICE ZKSCAN2, FZD7, LATS2 NPC1 2728/4885RAB9A 2242/4885POLB 4775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.